Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma

NCT00070291 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

NETWORK

Sponsor class

Stopped Slow accrual.

Conditions

Lymphoma

Interventions

DRUG: cyclosporine

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]